Qubit Pharmaceuticals Competitors and Similar CompaniesClear all
Qubit Pharmaceuticals's competitors and similar companies include ImmunoGen and Olema Oncology.
 Qubit Pharmaceuticals Qubit Pharmaceuticals is a company that provides physics-driven drug discovery solutions. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. | |
Founding Date | Founding Date 2020 | Founding Date 1981 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Paris, FR HQ | Locations Waltham, US HQ | Locations San Francisco, US HQ San Francisco, US |
Employees | Employees 701% decrease | Employees 277161% increase | Employees 9630% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.7 b | Valuation ($) 679.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) €76.7k (FY, 2023) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) N/A |
Net income | Net income (€133.4k) (FY, 2023) | Net income ($222.9m) (FY, 2022) | Net income ($162.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 56m | Total funding raised $ 145.1m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company